CBD and Dermatitis in Dogs: Veterinary Evidence Summary
Research Summary
CBD and Dermatitis in Dogs
There are a few studies looking at CBD use in the treatment of atopic dermatitis in dogs, and results are positive. Studies are summarised below:
Clinical research pattern
Across the studies summarised below, CBD or CBD/CBDA-rich supplementation was generally evaluated as an adjunct or supplement in dogs with canine atopic dermatitis or scratching behaviour. Findings included reductions in pruritus or scratching in several study designs, with alkaline phosphatase elevations noted in some treatment dogs.
Mogi et al. 2022 [1]
Method
The medical records of dogs supplemented with CBD were evaluated re signalment, physical examination, plasma C-reactive protein concentrations, pharmacologic management, the CAD Extent and Severity Index and the Pruritus Visual Analog Scale.
Findings
- CBD used as a supplement in combination with other drugs, was well-tolerated over a wide dose range and decreased the occurrence of pruritus in dogs with CAD when ingested twice a day.
- the use of CBD in combination with current CAD treatments suggested the possibility of reducing the dose of concomitant medications while increasing their efficacy.
Loewinger et al. 2022 [2]
Method
- Treatment dogs – received 2 mg/kg of an equal mix of CBD/CBDA
- Control – received a placebo
- Dosed twice daily with food for 28 days
Findings
- Over 65% of the dogs participating in the study had a substantial improvement in skin itchiness
- There was no significant difference in groups in terms of Dermatitis Extent and Severity Index.
- Elevated ALP was observed in 4/17 treatment dogs.
Mogi et al. 2022 [3]
Method
Treatments targeted at 0 and 2.5mg (LOW) and at 5.0mg (HIGH) CBD/kg BW per day split between two treats administered after twice-daily exercise
Findings
- CBD tended (P = 0.071) to reduce total daily scratching compared with the control.
- CBD reduced scratching compared with control (P = 0.030).